236 related articles for article (PubMed ID: 30677614)
1. Discovery and synthesis of sulfur-containing 6-substituted 5,8-dimethoxy-1,4-naphthoquinone oxime derivatives as new and potential anti-MDR cancer agents.
Huang G; Dong JY; Zhang QJ; Meng QQ; Zhao HR; Zhu BQ; Li SS
Eur J Med Chem; 2019 Mar; 165():160-171. PubMed ID: 30677614
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of sulfur-containing shikonin oxime derivatives as potential antineoplastic agents.
Huang G; Zhao HR; Meng QQ; Zhang QJ; Dong JY; Zhu BQ; Li SS
Eur J Med Chem; 2018 Jan; 143():166-181. PubMed ID: 29174813
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxicity of Synthesized 1,4-Naphthoquinone Oxime Derivatives on Selected Human Cancer Cell Lines.
Zhang Q; Dong J; Cui J; Huang G; Meng Q; Li S
Chem Pharm Bull (Tokyo); 2018; 66(6):612-619. PubMed ID: 29863062
[TBL] [Abstract][Full Text] [Related]
4. Nitrogen-containing ecdysteroid derivatives vs. multi-drug resistance in cancer: Preparation and antitumor activity of oximes, oxime ethers and a lactam.
Vágvölgyi M; Martins A; Kulmány Á; Zupkó I; Gáti T; Simon A; Tóth G; Hunyadi A
Eur J Med Chem; 2018 Jan; 144():730-739. PubMed ID: 29291440
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of novel alkannin and shikonin oxime derivatives as potent antitumor agents.
Wang R; Zhang X; Song H; Zhou S; Li S
Bioorg Med Chem Lett; 2014 Sep; 24(17):4304-7. PubMed ID: 25127868
[TBL] [Abstract][Full Text] [Related]
6. Target ROS to induce apoptosis and cell cycle arrest by 5,7-dimethoxy-1,4-naphthoquinone derivative.
Li K; Wang B; Zheng L; Yang K; Li Y; Hu M; He D
Bioorg Med Chem Lett; 2018 Feb; 28(3):273-277. PubMed ID: 29305189
[TBL] [Abstract][Full Text] [Related]
7. Design, Synthesis, and Biological Evaluation of Novel Thiazolyl Substituted Bis-pyrazole Oxime Derivatives with Potent Antitumor Activities by Selectively Inducing Apoptosis and ROS in Cancer Cells.
Xiong B; Chen S; Zhu P; Huang M; Gao W; Zhu R; Qian J; Peng Y; Zhang Y; Dai H; Ling Y
Med Chem; 2019; 15(7):743-754. PubMed ID: 30147012
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and In Vitro Antitumor Activity of Naringenin Oxime and Oxime Ether Derivatives.
Latif AD; Gonda T; Vágvölgyi M; Kúsz N; Kulmány Á; Ocsovszki I; Zomborszki ZP; Zupkó I; Hunyadi A
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31052551
[TBL] [Abstract][Full Text] [Related]
9. Discovery of potential anticancer multi-targeted ligustrazine based cyclohexanone and oxime analogs overcoming the cancer multidrug resistance.
Zha GF; Qin HL; Youssif BGM; Amjad MW; Raja MAG; Abdelazeem AH; Bukhari SNA
Eur J Med Chem; 2017 Jul; 135():34-48. PubMed ID: 28431353
[TBL] [Abstract][Full Text] [Related]
10. 2-Aryl-1,4-naphthoquinone-1-oxime methyl ethers: their cytotoxic activity.
Ishikawa T; Saito T; Kurosawa A; Watanabe T; Maruyama S; Ichikawa Y; Yamada R; Okuzawa H; Sato H; Ueno K
Chem Pharm Bull (Tokyo); 2011; 59(4):472-5. PubMed ID: 21467676
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of novel xanthine derivatives as potential apoptotic antitumor agents.
Hisham M; Youssif BGM; Osman EEA; Hayallah AM; Abdel-Aziz M
Eur J Med Chem; 2019 Aug; 176():117-128. PubMed ID: 31108261
[TBL] [Abstract][Full Text] [Related]
12. Novel quinoline derivatives carrying nitrones/oximes nitric oxide donors: Design, synthesis, antiproliferative and caspase-3 activation activities.
Abdelbaset MS; Abdel-Aziz M; Abuo-Rahma GEA; Abdelrahman MH; Ramadan M; Youssif BGM
Arch Pharm (Weinheim); 2019 Jan; 352(1):e1800270. PubMed ID: 30500087
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxicity and mode of action of a naturally occurring naphthoquinone, 2-acetyl-7-methoxynaphtho[2,3-b]furan-4,9-quinone towards multi-factorial drug-resistant cancer cells.
Kuete V; Mbaveng AT; Sandjo LP; Zeino M; Efferth T
Phytomedicine; 2017 Sep; 33():62-68. PubMed ID: 28887921
[TBL] [Abstract][Full Text] [Related]
14. A novel curcumin derivative which inhibits P-glycoprotein, arrests cell cycle and induces apoptosis in multidrug resistance cells.
Lopes-Rodrigues V; Oliveira A; Correia-da-Silva M; Pinto M; Lima RT; Sousa E; Vasconcelos MH
Bioorg Med Chem; 2017 Jan; 25(2):581-596. PubMed ID: 27908756
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, anticancer activity and QSAR study of 1,4-naphthoquinone derivatives.
Prachayasittikul V; Pingaew R; Worachartcheewan A; Nantasenamat C; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
Eur J Med Chem; 2014 Sep; 84():247-63. PubMed ID: 25019480
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of naphthoquinone phenacylimidazolium derivatives.
Yuan J; Liu Z; Zhang Z; Yan D; Zhang W
Bioorg Med Chem Lett; 2021 Jun; 41():127977. PubMed ID: 33766771
[TBL] [Abstract][Full Text] [Related]
17. Discovery of new pyrimidopyrrolizine/indolizine-based derivatives as P-glycoprotein inhibitors: Design, synthesis, cytotoxicity, and MDR reversal activities.
Shawky AM; Abdalla AN; Ibrahim NA; Abourehab MAS; Gouda AM
Eur J Med Chem; 2021 Jun; 218():113403. PubMed ID: 33823396
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of novel cytotoxic azanaphthoquinone annelated pyrrolo oximes.
Shanab K; Pongprom N; Wulz E; Holzer W; Spreitzer H; Schmidt P; Aicher B; Müller G; Günther E
Bioorg Med Chem Lett; 2007 Nov; 17(22):6091-5. PubMed ID: 17904839
[TBL] [Abstract][Full Text] [Related]
19. Click chemistry-assisted synthesis of novel aminonaphthoquinone-1,2,3-triazole hybrids and investigation of their cytotoxicity and cancer cell cycle alterations.
Gholampour M; Ranjbar S; Edraki N; Mohabbati M; Firuzi O; Khoshneviszadeh M
Bioorg Chem; 2019 Jul; 88():102967. PubMed ID: 31078767
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of novel 1,2-bis-quinolinyl-1,4-naphthoquinones: ERK2 inhibition, cytotoxicity and molecular docking studies.
Aly AA; El-Sheref EM; Bakheet MEM; Mourad MAE; Brown AB; Bräse S; Nieger M; Ibrahim MAA
Bioorg Chem; 2018 Dec; 81():700-712. PubMed ID: 30268050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]